XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities:    
Net income (loss) $ (5,295) $ 9,471
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Stock-based compensation expense 10,901 7,790
Amortization of intangible assets 11,445 13,270
Amortization of costs capitalized to obtain revenue contracts 1,247 1,091
Depreciation and amortization 1,380 1,187
Bad debt expense 1,090 564
Amortization of investment premiums & other (1,756) (64)
Accretion and amortization on debt securities 6,015 5,609
Net changes in estimated fair value of acquisition-related contingent consideration 136 2,093
Deferred taxes (2,187) (8,246)
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable (10,363) (9,180)
Contract assets 5,527 (3,758)
Other assets (8,840) (1,164)
Accounts payable (1,358) 2,633
Accrued payroll and related taxes 249 (1,099)
Income taxes payable (4,125) 9,865
Deferred revenue 6,568 (1,155)
Restructuring accrual 42 (971)
Other liabilities (90) 177
Net cash provided by (used in) operating activities 10,586 28,113
Investing activities:    
Purchases of investments (45,185) (23,723)
Sales and maturities of investments 74,172 50,000
Purchases of property and equipment, net (1,155) (656)
Net cash provided by (used in) investing activities 27,832 25,621
Financing activities:    
Payment of revolving credit line issuance costs (290) 0
Proceeds from the issuance of equity plan common stock 1,048 1,351
Repurchases and retirements of common stock (10,040) 0
Payment of acquisition-related contingent consideration (4,641) 0
Proceeds from other borrowings 1,175 0
Principal payments on other borrowings (123) (36)
Net cash provided by (used in) financing activities (12,871) 1,315
Foreign currency effect on cash and cash equivalents (109) 382
Net increase in cash and cash equivalents 25,438 55,431
Cash and cash equivalents at beginning of period 58,913 32,059
Cash and cash equivalents at end of period 84,351 87,490
Supplemental disclosures of cash flow information:    
Issuance of common stock for acquisition-related contingent consideration 3,471 0
Cash paid for interest 685 602
Cash paid for income taxes 11,942 2,057
Supplemental disclosures of non-cash investing and financing activities:    
Unrealized holding gain on available for sale investments $ 93 $ 771